Study to Evaluate ctDNA of mCSPC Patients Receiving Apalutamide in Japan

NCT04601441 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Castration-sensitive Prostate Cancer

Interventions

DRUG: Apalutamide

Sponsor

Kindai University

Collaborators

[object Object]